BACKGROUND: COPD is a global concern. Currently, several sets of guidelines, statements and strategies to managing COPD exist around the world. METHODS: The Czech Pneumological and Phthisiological Society (CPPS) has commissioned an Expert group to draft recommended guidelines for the management of stable COPD. Subsequent revisions were further discussed at the National Consensus Conference (NCC). Reviewers' comments contributed to the establishment of the document's final version. DIAGNOSIS: The hallmark of the novel approach to COPD is the integrated evaluation of the patient's lung functions, symptoms, exacerbations and identifications of clinical phenotype(s). The CPPS defines 6 clinically relevant phenotypes: frequent exacerbator, COPD-asthma overlap, COPD-bronchiectasis overlap, emphysematic phenotype, bronchitic phenotype and pulmonary cachexia phenotype. TREATMENT: Treatment recommendations can be divided into four steps. 1(st) step = Risk exposure elimination: reduction of smoking and environmental tobacco smoke (ETS), decrease of home and occupational exposure risks. 2(nd) step = Standard treatment: inhaled bronchodilators, regular physical activity, pulmonary rehabilitation, education, inhalation training, comorbidity treatment, vaccination. 3(rd) step = Phenotype-specific therapy: PDE4i, ICS+LABA, LVRS, BVR, AAT augmentation, physiotherapy, mucolytic, ABT. 4(th) step = Care for respiratory insufficiency and terminal COPD: LTOT, lung transplantation, high intensity-NIV and palliative care. CONCLUSION: Optimal treatment of COPD patients requires an individualised, multidisciplinary approach to the patient's symptoms, clinical phenotypes, needs and wishes. The new Czech COPD guideline reflects and covers these requirements.

Pulmonary Department Faculty of Medicine in Hradec Kralove Charles University Prague and University Hospital Hradec Kralove Czech Republic

Citace poskytuje Crossref.org

Effect of Treatment with Mucoactive Drugs on COPD Exacerbations During 5 years of Follow-up in the Czech Republic: A Real-World Study

Inhaled therapies in patients with moderate COPD in clinical practice: current thinking

Chronic obstructive pulmonary disease guidelines in Europe: a look into the future

Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study

Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review

Diagnosing COPD: advances in training and practice - a systematic review

POPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern Europe

A review of national guidelines for management of COPD in Europe

Czech multicenter research database of severe COPD

Real-life GOLD 2011 implementation: the management of COPD lacks correct classification and adequate treatment